Navamedic ASA (OSL:NAVA)

Navamedic ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	463	571	454	637	601	556
Market Cap Growth	36.48%	25.74%	-28.72%	5.92%	8.19%	90.28%
Enterprise Value	600	831	534	720	625	561
Last Close Price	19.30	23.80	25.27	36.09	34.32	33.43
PE Ratio	-	-	-	-	20.43	899.28
PS Ratio	0.81	1.01	0.85	1.24	1.57	2.00
PB Ratio	1.48	1.71	2.10	3.10	2.87	3.68
P/TBV Ratio	-	-	-	-	7.67	8.84
P/FCF Ratio	39.07	24.60	12.60	-	38.32	-
P/OCF Ratio	32.57	22.31	11.54	292.27	33.51	-
EV/Sales Ratio	1.05	1.47	1.01	1.41	1.64	2.02
EV/EBITDA Ratio	12.70	18.63	12.30	14.65	12.60	34.77
EV/EBIT Ratio	67.38	51.11	16.81	18.17	14.07	49.01
EV/FCF Ratio	50.69	35.80	14.83	-	39.84	-
Debt / Equity Ratio	0.65	0.62	0.55	0.74	0.28	0.31
Debt / EBITDA Ratio	4.33	4.37	2.55	2.96	1.14	2.57
Debt / FCF Ratio	17.29	8.97	3.29	-	3.74	-
Net Debt / Equity Ratio	0.44	0.40	0.38	0.56	0.02	-0.04
Net Debt / EBITDA Ratio	3.11	3.01	1.87	2.34	0.07	-0.37
Net Debt / FCF Ratio	11.62	5.78	2.26	-6045.00	0.22	2.96
Asset Turnover	0.97	0.94	1.09	1.15	1.07	0.94
Inventory Turnover	3.45	3.51	3.48	3.39	3.09	3.21
Quick Ratio	0.76	0.69	0.66	0.49	0.90	0.78
Current Ratio	1.47	1.45	1.42	1.11	1.93	1.51
Return on Equity (ROE)	-6.15%	-8.55%	-2.60%	-6.59%	16.31%	0.44%
Return on Assets (ROA)	0.95%	1.68%	4.08%	5.57%	7.79%	2.43%
Return on Invested Capital (ROIC)	1.94%	4.24%	10.29%	14.86%	17.17%	2.33%
Return on Capital Employed (ROCE)	1.70%	2.90%	9.70%	12.50%	17.30%	5.90%
Earnings Yield	-3.50%	-4.12%	-1.21%	-2.15%	4.90%	0.11%
FCF Yield	2.56%	4.06%	7.94%	-0.00%	2.61%	-0.36%
Buyback Yield / Dilution	-15.96%	-8.91%	-1.24%	-1.48%	-3.60%	-13.61%

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.